Enzymatica AB

medical devices

About

Enzymatica AB is a Swedish life science company based in Lund, specializing in healthcare products that address infections and symptoms in the upper respiratory tract. Founded in 2007, the company focuses on enzyme-based medical devices that create a protective barrier against viruses and irritants. Its flagship product, ColdZyme® Mouth Spray, is designed to prevent the common cold and alleviate its symptoms by supporting the body's natural defenses. The company also offers enzyme formulations for skin care, leveraging its expertise in enzyme technology. Enzymatica markets its products through contract organizations and established partners, aiming for geographic expansion. ColdZyme® has been launched in about ten markets worldwide and is supported by independent scientific studies that confirm its efficacy in reducing cold symptoms and the number of sick days. Enzymatica is publicly traded on the Nasdaq Stockholm exchange under the ticker symbol ENZY and employs around 21 people.

Technologies

Outlook Microsoft Office 365 Microsoft Azure Hosting Mobile Friendly

Keywords

cold & flu barrier technology enzyme medical equipment manufacturing medical devices regulatory compliance enzyme-based solutions medical equipment and supplies manufacturing scientific research clinical studies health support independent studies coldzyme mouth spray sars-cov-2 protection respiratory health upper respiratory tract protection in vitro studies viral infection cycle disruption product development sustainability covid-19 virus inactivation elite athlete studies viral deactivation health care equipment & supplies b2c e-commerce personal care barrier technology platform virus inactivation respiratory infections

Location

19 Scheelevaegen, Lund, Skane County, Sweden, 223 63

Related Companies

Companies in the same industry